Stanford University
Stanford, California, 94305, United States
NCT Number: NCT03081767
The investigators wish to determine if standard and digital PET/CT scanners provide equivalent results for disease detection and diagnosis.
Looking for future studies?
Notify MeThere will be a single injection of the PET radiopharmaceutical followed by a standard PET/CT scan and immediately after by the digital PET/CT scan, or vice versa. The investigators wish to determine if image quality is equivalent with the digital PET/CT scanner.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Division of Nuclear Medicine and Molecular Imaging at Stanford has installed the first ever GE-made digital PET/CT scanner worldwide. The investigators wish to determine if the digital PET/CT scanner offers equivalent image quality as the standard PET/CT scanner.
Time frame: an expected average of 3 hours
Diagnostic image quality will be determined using a 5-point Likert Scale that reads:
5 - Diagnostic: Excellent diagnostic image quality;
4 - Diagnostic: Good diagnostic image quality;
3 - Diagnostic: Acceptable diagnostic image quality;
2 - Sub-optimal diagnostic: image quality with limited additional clinical information;
1 - Non-diagnostic: non-diagnostic image quality
Stanford University
Other
Comparison of Standard PET/CT vs. Digital PET/CT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03739372
Astrocytoma, Cancer
San Diego, California, United States
View Trial DetailsNCT02108028
Cancer, Chronic Disease
Orange, California, United States
View Trial DetailsNCT05156931
Cancer, Neoplasms
Clermont-Ferrand, France
View Trial DetailsNCT07073807
Behavior, Behavioral Symptoms
Irvine, California, United States
View Trial Details